Novartis, a leading global medicines company, and consistently ranked among the world’s top companies investing in research and development signed an MoU with Aster DM Healthcare, one of the largest integrated healthcare providers in the Middle East, with a wide network of 27 hospitals, 126 clinics labs, and over 300 pharmacies across 7 countries.
The MoU will enable Aster to access Novartis’ advanced therapy platforms and data science to further strengthen treatment outcomes for patients in UAE and beyond.
As a part of this collaboration, Novartis will be empowering data generation, ideation, impactful decision making for Aster DM Healthcare’s clinical research program. The firms have plans to initiate a series of workshops, training, and educational activities, that will assist Aster in commencing its activities on clinical research.
This collaboration is primarily focused on digital transformation and clinical research that will aim to identify current gaps in patient care and the introduction of extensive medical programs utilizing innovative data platforms and data syndicated designs.
This is in alignment with Aster’s long-term plan to integrate clinical research and digital transformation into its operations in UAE and beyond which will have a significant impact on the clinical outcome delivery for patients.
Dr. Azad Moopen, Founder Chairman, and Managing Director, Aster DM Healthcare stated: “Data Analytics with a focus on clinical research is one of the cornerstones of healthcare in the future. Aster tries to stay ahead of the curve in offering the best medical solutions to our patients and equipping our doctors with the most advanced systems to be able to do so. We have associated with Novartis in the past and are glad to enter into a multi-faceted partnership to enhance Digital Transformation and Research.”
Mohamed Ezz Eldin, President and Head of Gulf Cluster, Novartis Pharmaceuticals stated: “At Novartis, we are committed to building new partnerships as part of our efforts to improve access to quality healthcare. Aster DM Healthcare is a valuable partner for us in this journey. We truly believe that we share a common vision, and we are confident that this partnership has the potential to add value and have an impact on patients in UAE. We are happy to collaborate with Aster to realize their vision towards data transformation and clinical research, both of which are tantalizing growth areas for the healthcare sector.”
Novartis a leading global medicines company, utilizes innovative science and digital technologies to develop transformative treatments in areas of urgent medical need and will continue to reimagine medicine to improve and extend people’s lives.
Press Release received on mail
